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Background: Panicum maximum is used as malarial remedy traditionally and the leaf extract has been found to 
possess antimalarial, analgesic and anticancer properties. 
Objective: The ethanol root extract of Panicum maximum were evaluated for antiplasmodial and analgesic activities 
in rodents.  
Methods: The crude root extract (137 – 547mg/kg) of Panicum maximum were investigated for antiplasmodial 
activity against chloroquine sensitive Plasmodium berghei infections in mice. The antiplasmodial activity during early 
and established infections as well as prophylactic were investigated. Artesunate 5mg/kg and pyrimethamine 
1.2mg/kg were used as positive controls. Analgesic activity of the crude extract/fractions was also evaluated against 
acetic acid, formalin and heat-induced pains.  
Results: The extract dose-dependently reduced parasitaemia induced by chloroquine sensitive Plasmodium berghei 
infection in prophylactic, suppressive and curative models in mice. These reductions were statistically significant 
(p<0.001). They also improved the mean survival time (MST) from 13 to 28 days relative to control (p<0.001).  The 
activity of extract was weak compared to that of the standard drugs used (artesunate and pyrimethamine). On 
chemically and thermally- induced pains, the extract inhibited acetic acid and formalin-induced inflammation as well 
as hot plate-induced pain in mice. These inhibitions were statistically significant (p<0.001) and in a dose-dependent 
fashion.  
Conclusion: Panicum maximum root extract has antiplasmodial and analgesic activities which may in part be 
mediated through the chemical constituents of the plant.                                                              
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1. Introduction 
Panicum maximum Jacq (Poacace) is a perennial, tuft 
grass with a short, creeping rhizome regarded as the 
most valuable fodder plant and extensively used to 
make hay. The stem of this robust grass can reach a 
height of up to 2m, the leaf sheath are found at the bases 
of the stems and are covered in fine hairs. It is widely 
distributed in Africa where it originates and almost all 
tropical parts of the world (Van Oudtshoorn, 1999). The 
plant (leaf) is use traditionally by the Ibibios of Akwa 
Ibom State, Nigeria in the treatment of various ailments 
such as malaria, microbial infections, rheumatism pain, 
inflammation and diabetes. Antidiabetic (Antia et al, 
2010), antimalarial and analgesic (Okokon et al, 2012), 
antibacterial (Gothandam et al, 2010; Doss et al, 2011a; 
Doss et al, 2011b), anti-inflammatory and antipyretic 
(Okokon et al, 2011) and antifungal (Kanife, 2012), 
anticancer, antioxidative burst, antileishmanial 
activities of the leaf extract have been reported (Okokon 
et al, 2014). Phytochemical components such as phytol, 
pentadecanoic acid, Hexadecanoic acid, dodecanoic acid, 
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8,11,14-eicosatrienoic acid (Z,Z,Z), mono and 
sequiterpenes such as  terpinen-4-ol, borneol and 
germanicol have been reported on the leaf extract 
(Okokon et al, 2014).  Ethnopharmacological and 
scientific reports on the root of this plant is scarce. In 
this study, we investigated the antimalarial and 
phytochemical components of ethanol root extract of 
Panicum maximum. 
2. Materials and Methods 
2.1 Plants collection 
The fresh roots of Panicum maximum were collected in 
August, 2015 at Farmland in Uyo, Uyo LGA, Akwa Ibom 
State, Nigeria. The roots were identified and 
authenticated as Panicum maximum a taxonomist in the 
Department of Botany and Ecological studies, University 
of Uyo, Uyo. Nigeria. Herbarium Specimen was 
deposited at the Faculty of Pharmacy Herbarium (FPH 
76c), University of Uyo, Nigeria. 
2.2 Extraction 
The plant parts (roots) were washed and air- dried on 
laboratory table for 2 weeks. The dried roots were 
pulverized using a pestle and mortar. The powdered 
root was macerated in 95% ethanol for 72 hours. The 
liquid ethanol extract obtained by filtration was 
evaporated to dryness in a water bath at 600C. The yield 
of the extract was stored in a refrigerator at -40C until it 
was used for the experiment reported in this study. 
2.3 Phytochemical Screening 
Phytochemical screening of the crude root extract was 
carried out employing standard procedures and tests 
(Trease and Evans, 1996, Sofowora, 1993), to reveal the 
presence of chemical constituents such as alkaloids, 
flavonoids, tannins, terpenes, saponins, anthraquinones, 
reducing sugars, and cardiac glycosides and others. 
2.4 Animals 
The animals (Swiss albino mice) of either sex were used 
for these experiments. The animals were housed in 
standard cages and were maintained on a standard 
pelleted feed (Guinea feed) and water ad libitum. 
Permission and approval for animal studies were 
obtained from the College of Health Sciences Animal 
Ethics Committee, University of Uyo. 
2.5 Microorganisms 
A chloroquine sensitive strain of Plasmodium berghei 
(ANKA) was obtained from the National Institute of 
Medical Research (NIMER), Yaba Lagos, Nigeria and was 
maintained by sub-passage in mice. 
2.6  Determination of Median Lethal Dose (LD50)  
The median lethal dose (LD50) of the extract was 
estimated using albino mice by intraperitoneal (i.p) 
route using the method described by Lorke (1983).  
This involved intraperitoneal administration of 
different doses of the extract (1000, 2000, 2500, 3000, 
4000 and 5000 mg/kg) to groups of five mice each. The 
animals were observed for manifestation of physical 
signs of toxicity such as writhing, decreased motor 
activity, decreased body/limb tone, decreased 
respiration and death. The number of deaths in each 
group within 24 hours was recorded. The LD50 was 
calculated as geometrical means of the maximum dose 
producing 0% (a) and the minimum dose producing 
100% mortality (b). 
 LD50 =√ab 
2.7 Parasite Inoculation 
Each mouse used in the experiment was inoculated 
intraperitoneally with 0.2ml of infected blood 
containing about 1 x 107 P. berghei berghei parasitized 
erythrocytes. The inoculum consisted of 5 x 107 P. 
berghei berghei erythrocytes per ml. This was prepared 
by determining both the percentage parasitaemia and 
the erythrocytes count of the donor mouse and diluting 
the blood with isotonic saline in proportions indicated 
by both determinations (Odetola and Basir, 1980). 
2.8 Drug Administration 
The drug (artesunate), extract  used in the 
antiplasmodial study were orally administered with the 
aid of a stainless metallic feeding cannula. 
2.9 Evaluation of anti-plasmodial activity of 
ethanol crude root extract of Panicum maximum 
Evaluation of suppressive activity of the extract (4-
day test). 
This test was used to evaluate the schizontocidal 
activity of the extract and artesunate against early P. 
berghei berghei  infection in mice.  This was done as 
described by Knight and Peters (1980). Thirty mice 
were randomly divided into five groups of six mice each. 
On the first day (DO), the 30 mice were infected with the 
parasite and randomly divided into various groups. 
These were administered with the extract and 
artesunate.  The mice in group 1 were administered 
with the 137 mg/kg, the group 2, 273 mg/kg and group 
3, 547 mg/kg of crude extract , while group 4 was 
administered  with 5 mg/kg of artesunate (positive 
control), and 10ml/kg of distilled water to group 5 
(negative control) for four consecutive days (D0 – D3) 
between 8am and 9am. On the fifth day (D4), thin blood 
film was made from tail blood. The film was then 
stained with leishman stain to reveal parasitized 
erythocytes out of 500 in a random field of the 
microscope. The average percentage suppression of 
parasitaemia was calculated in comparison with the 
controls as follows: 
Average % parasitaemia 
in negative control - 
Average % parasitaemia 
in Positive groups 
Average % parasitaemia in negative control. 
 
Evaluation of prophylactic or repository activities of 
extract  
The repository activity of the extract and artesunate 
was assessed by using the method described by Peters 
(1965). The mice were randomly divided into seven 
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groups of six mice each. Groups 1 - 3 were administered 
with 137, 273 and 547 mg/kg/day of the extract 
respectively,  Groups 4 and 5 were respectively 
administered with 1.2 mg/kg/day of pyrimethamine 
(positive control) and  10 ml/kg of distilled water 
(negative control). Administration of the extract/drug 
continued for three consecutive days (D0 – D2). On the 
fourth day (D3) the mice were inoculated with P. berghei 
berghei. The parasitaemia level was assessed by blood 
smears seventy-two hours later.   
Evaluation of curative activities of extract (Rane’s 
test)  
This was used to evaluate the schizontocidal activity of 
the extract, and artesunate in established infection. This 
was done as described by Ryley and Peters (1970). P. 
berghei berghei was injected intraperitoneally into 
another 30 mice on the first day (DO). Seventy–two 
hours later (D3), the mice was divided randomly into 
five groups of six mice each. Different doses of the 
extract, 137 mg/kg, 273 mg/kg and 547 mg/kg were 
orally administered respectively to mice in groups 1-3. 
5 mg/kg/day of artesunate  was administered to the 
group 4 (positive control) and group 5 was given 10 
ml/kg of distilled water (negative control).  The extract 
and drugs were administered once daily for 5 days. 
Leishman’s stained thin smears were prepared from tail 
blood samples collected on each day of treatment to 
monitor parasitaemia level. The mean survival time 
(MST) of the mice in each treatment group was 
determined over a period of 29 days (D0 – D28). 
No of days survived 
x 100 = MST 
Total No. of days (29) 
 
2.10 Evaluation of analgesic potential of the extract  
Acetic acid induced writhing in mice 
Intraperitoneal (i.p) injection of 2% acetic acid was 
used to induce writhings (abdominal constrictions 
consisting of the contraction of abdominal muscles 
together with the stretching of hindlimbs) according to 
the procedure described by Santos et al. (1994), Correa 
et al. (1996) and Nwafor et al, (2010). The animals were 
divided into 5 groups of 6 mice per group. Group 1 
served as negative control and received 10 ml/kg of 
normal saline, while groups 2, 3 and 4 were pre-treated 
with 137 , 273  and 547 mg/kg doses of P. maximum 
root extract intraperitoneally, and group 5 received 100 
mg/kg of acetyl salicylic acid. After 30 minutes, 0.2 ml of 
2% acetic acid was administered intraperitoneally (i.p). 
The number of writhing movements was counted for 30 
minutes. Antinociception (analgesia) was expressed as 
the reduction of the number of abdominal constrictions 
between control animals and mice pretreated with 
extracts. 
Thermally induced pain in mice 
The effect of extract on hot plate induced pain was 
investigated in adult mice. The hot plate was used to 
measure the response latencies according to the 
method of Vaz et al, (1996) and Okokon and Nwafor, 
(2010). In these experiments, the hot plate was 
maintained at 45±1oC, each animal was placed into a 
glass beaker of 50 cm diameter on the heated surface, 
and the time(s) between placement and shaking or 
licking of the paws or jumping was recorded as the 
index of response latency. An automatic 30-second cut-
off was used to prevent tissue damage. The animals 
were randomly divided into 5 groups of 6 mice each and 
fasted for 24 hours but allowed access to water. Group 1 
animal served as negative control and received 10 
ml/kg of normal saline. Groups 2, 3 and 4 were pre-
treated intraperitoneally with 137 , 273  and 547 mg/kg 
doses of P. maximum extract respectively, while group 5 
animals  received 100 mg/kg of acetyl salicylic acid 
intraperitoneally, 30 minutes prior to the placement on 
the hot plate.  
2.11 Statistical analysis and data evaluation 
 Data obtained from this work were analyzed 
statistically using  Students’ t-test and ANOVA (One- or 
Two- way) followed by a  post test (Turkey-Kramer 
multiple comparison  test). Differences between means 
was considered significant at 1% and 5% level of 
significance, that is P ≤ 0.01and 0.05. 
3.  Results  
3.1 Phytochemical Screening 
Phytochemical screening of the crude root extract was 
carried out employing standard procedures and tests 
revealed the presence of chemical constituents such as 
alkaloids, flavonoids, tannins, terpenes, saponins, 
cardiac glycosides among others. 
3.2 Determination of Median Lethal Dose (LD50) 
The various doses employed in the study produced 
different degrees of mortality (Table 1). The median 
lethal dose (LD50) was calculated to be 2738.1 mg/kg. 
The physical signs of toxicity included excitation, paw 
licking, increased respiratory rate, decreased motor 
activity, gasping and coma which was followed by 
death. These signs were dose dependent. 
Table 1: Acute toxicity profile of ethanolic root extract 
of Zea mays 
Doses (mg/kg) Mortality 
1000 0/3 
2000 0/3 
2500 0/3 
3000 3/3 
5000 3/3 
 
3.3 Effect on suppressive activity of ethanol root 
extract of P. maximum 
The extract showed a dose-dependent 
chemosuppressive effect on the parasitaemia. These 
effects were statistically significant relative to the 
control (p<0.05 - 0.001). The chemoinhibitory 
percentages ranged from 38.71 to 75.80 (Table 2). 
However, the effect of the extract was still much lower 
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than that of artesunate, which exhibited a 
chemosuppression of 98.74% (Table 2). 
3.4 Effect on repository activity of ethanol root 
extract of P. maximum 
The ethanol root extract of P. maximum showed a dose-
dependent chemosuppressive effect (35.47 – 54.04%) 
on the parasitaemia during prophylactic studies. These 
effects were statistically significant relative to the 
control (p<0.001).  
However these effects were still much lower than that 
of pyrimethamine which exhibited chemosuppression 
of 90.92 % (Table 3). 
3.5 Antiplasmodial effect of ethanol root extract of 
P. maximum on established infection 
The extract showed a dose- dependent schizonticidal 
effect on the parasitaemia. There were reductions in the 
percentage parasitaemia of the extract/ artesunate-
treated groups compared to that of the control in which 
prominent increases were recorded. These reductions 
were statistically significant relative to the control 
(p<0.05 - 0.001) (Figure 1). Though the extract showed 
a significant  (p<0.05 - 0.001), dose -dependent  mean 
survival time on established infection (12.66 – 15.66 
days), the effect of the extract (137 – 547 mg/kg) was 
weak compared to that of the standard drug, artesunate 
(Table 4). 
3.6 Effect of ethanol root extract of P. maximum on 
acetic acid-induced writhing in mice 
The administration of P. maximum extract (137 , 273  
and 547 mg/kg) demonstrated a dose-dependent 
reduction in acetic acid-induced writhing in mice. The 
reductions were statistically significant (p<0.05 - 0.001) 
relative to control and the effect of the highest dose(547 
mg/kg) at 30 minute was more than that of the 
standard drug, ASA (Table 5). 
    
   Table 2: Suppressive Activities of root extract of Panicum maximum (4-day test). 
Drug/extract Dose (mg/kg) Parasitaemia % Chemosuppression 
Distilled water 10ml/kg 41.33 ± 6.67 _ 
Extract 137 25.33 ±5.84a 38.71 
273 21.33 ± 1.85b 48.39 
547 10.00 ± 0.57b 75.80 
Artesunate 5 0.52 ± 0.01b 98.74 
   Values are expressed as mean + S.E.M. Significance relative to control: a P < 0.05; b P<0.001: n=6 
 
Table 3: Repository/Prophylactic activity of root extract of Panicum maximum on Plasmodium berghei 
infection in mice 
Treatments Dose(mg/kg) Parasitaemia % Chemosuppression 
Normal saline  10ml/kg 14.66±0.66 - 
Crude extract 137 9.46± 2.15a 35.47 
273 7.40±5.68a 49.52 
547 6.73 ±3.11 a 54.09 
Pyrimethamine 1.2 1.33±0.66 a 90.92 
     Values are expressed as mean ± SEM. Significance relative to control a P < 0.001.  n = 6. 
 
Table 4: Mean Survival Time (MST) of Mice receiving different doses of root extract of Panicum maximum 
during established infection 
Drug/extract Dose(mg/kg) MST (days) 
Distilled water 10ml/kg 11.66±0.88 
Extract 137 12.66 ± 0.33 
273 14.00 ±0.57a 
547 15.66± 0.33c 
Artesunate 5 30.00 ± 0.00 c 
   Values are expressed as mean ±S.E.M. Significance relative to control: a P < 0.05; b P < 0.001, n=6. 
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3.7 Effect of ethanol root extract of P. maximum on 
thermally-induced pain in mice. 
The extract (137, 273 and 547 mg/kg) exhibited a dose-
dependent effect on thermally-induced pain in mice. 
These inhibitions were statistically significant (p<0.05) 
only at the highest dose of the extract (547 mg/kg) 
relative to the control but weak compared to that of the 
standard drug, ASA (100mg/kg) (Table  6). 
     Figure 1: Antiplasmodial activity of root extract of Panicum maximum (Curative test). 
 
Table 5: Effect of P. maximum root extract on acetic acid induced writhing in mice. 
Treatment 
Time intervals (hr) 
5 10 15 20 25 30 Total 
Control 8.32 ± 0.18 13.24 ± 1.11 22.66 ± 1.85 18.10 ± 0.38 15.45 ± 0.15 12.0 ± 1.10 89.77 ± 4.77 
Extract 
137 mg/kg 
 
4.33 ± 0.66 a 
 
3.00 ± 1.12 a 
 
10.53 ± 0.15a 
 
12.11 ± 1.20   
 
10.38 ± 0.67 a  
 
9.56 ± 0.35  
 
49.91 ± 4.15c 
273 mg/kg 3.00 ± 0.57 c 2.33 ± 0.35 b 8.42 ± 1.65b 10.24 ± 0.28a 8.56 ± 1.58 b 7.15 ± 0.38a 39.70 ± 4.81c 
547 mg/kg 2.00 ± 0.57c 2.00 ± 0.57b 8.12 ± 0.44c 8.55 ± 0.46b 5.00 ± 0.26c 6.30 ± 0.76b 31.97 ± 3.06c 
ASA 100 mg/kg 4.00 ± 0.51 a 3.00 ± 0.22a 6.33 ± 0.18c 7.89 ± 0.55c 6.32 ± 0.16c 4.00 ± 0.57c  31.54 ± 2.19c 
Data are expressed as mean ± SEM. significant at a P < 0.05, b P <  0.01, c P < 0.001 when compared to control n = 6. 
 
    Table 6: Effect of P. maximum root extract on hot plate test 
Group Dose (mg/kg) 
Reaction time (sec) 
(mean ± SEM) 
% inhibition 
Control - 4.92 ± 0.23  
P. maximum 137 6.59 ± 0.27 33.94 
 273 8.24 ± 0.11 67.47 
 547 13.46 ± 0.21a 173.57 
ASA 100 29.53 ± 3.48c 500.20 
    Data are expressed as mean ± SEM.  Significant at a P < 0.05, b P < 0.001 when compared to control. n = 6. 
 
4. Discussion 
In this work, median lethal dose (LD50) was determined 
to be 2738.61 mg/kg, and the extract was found to be 
relatively safe with slight toxicity (Homburger, 1989). 
The antiplasmodial activity of root extract of P. 
maximum was also investigated using standard models. 
It was found that the extract significantly reduced the 
parasitaemia in prophylactic, suppressive and curative 
models in a dose - dependent fashion.  
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These results corroborate our previously reported 
findings of significant antiplasmodial activity in the leaf 
extract of this plant (Okokon et al, 2011). 
 Some secondary metabolites of plants have been 
reported to have antiplasmodial activity. Among these 
metabolites are flavonoids, alkaloids and triterpenoids 
(Philipson and Wright, 1991; Christensen and 
Kharazmi, 2001; Kirby et al, 1989).  
The root extract of P. maximum have been found to 
contain alkaloids, saponins, tannins, phlabatannins, 
flavonoids and cardiac glycosides among others. Also 
the leaf extract of P. maximum has been found to contain 
mono and sequiterpenes such as terpinen-4-ol, borneol 
and germanicol (Okokon et al, 2014) which are likely to 
be present in the root. Flavonoids are known to exert 
antiplasmodial activity by chelating with nucleic acid 
base pairing of the parasite (Lui et al, 1992), thereby 
producing plasmocidal effect and triterpenes like 
quassinoids are potent protein inhibitors (Liao et al, 
1976). These compounds (flavonoids and triterpenoids) 
present in this plant extract may in part have 
contributed to the plasmocidal activity of this extract 
and therefore explained the mechanism of 
antiplasmodial effect of the extract. 
Phytochemical compounds such as terpenes and their 
derivatives such as monoterpenes and sesquiterpenes 
have been implicated in antiplasmodial activity of many 
plants (Philipson and Wright, 1991; Christensen and 
Kharazmi, 2001). Monoterpenes such as limonene have 
been implicated in endoperoxidation leading to 
plasmocidal activity (Hatzakis et al, 2000). These could 
have also contributed to the antiplasmodial activity of 
this extract 
The extract significantly reduced acetic acid-induced 
writhing and delayed the reaction time of animals 
(mice) to thermally induced pain. Acetic acid causes 
inflammatory pain by inducing capillary permeability 
(Amico-Roxas et  al.,1984;  Nwafor et  al., 2007), and in 
part through local peritoneal receptors  from peritoneal 
fluid concentration of PGE2 and PGF2α (Deraedt et 
al,1980;  Bentley et al,1983). The acetic acid-induced 
abdominal writhing is a visceral pain model in which 
the processor releases arachidonic acid via 
cyclooxygenase, and prostaglandin biosynthesis plays a 
role in the nociceptive mechanism (Franzotti et al, 
2002). It is used to distinguish between central and 
peripheral pain. These results suggest that the extract 
may be exerting its action partly through the 
lipoxygenase and/or cyclooxygenase system.  
The organic acid has also been suggested to induce the 
release of endogenous mediators indirectly, which 
stimulates the nociceptive neurons that are sensitive to 
NSAIDs and narcotics (Adzu et al,2003). The inhibition 
of acetic acid-induced writhing by the extract at all the 
doses suggests antinociceptive effect which might have 
resulted from the inhibition of the synthesis of 
arachidonic acid metabolites. 
The study also shows that the extract significantly 
delayed the reaction time of thermally- induced (hot 
plate) test. This model is selective for centrally acting 
analgesics and indicates narcotic involvement (Turner, 
1995) with opioid receptors. 
The root extract of P. maximum have been reported 
above to contain alkaloids, saponins, tannins, 
phlabatannins, flavonoids and cardiac glycosides among 
others which might have contributed to the observed 
analgesic activity in this study. 
Flavonoids are known anti-inflammatory compounds 
acting through inhibition of the cyclo-oxygenase 
pathway (Liang et al, 1999). Some flavonoids are 
reported to block both the cyclooxygenase and 
lipoxygenase pathways of the arachidonate cascade at 
relatively high concentrations, while at lower 
concentrations they only block lipoxygenase pathway 
(Carlo et al, 1999). Some flavonoids exert their 
antinociception via opioid receptor activation activity 
(Suh et al, 1996; Rajendran et al, 2000; Otuki et al, 
2005). Flavonoids also exhibit inhibitory effects against 
phospholipase A2 and phospholipase C (Middleton et al, 
2000), and cyclooxygenase and/or lipoxygenase 
pathways (Robak et al, 1998). 
Triterpenes have been implicated in analgesic activities 
of plants (Liu, 1995; Krogh et al, 1999; Tapondjou et al, 
2003; Maia et al, 2006). Other secondary metabolites of 
plants such as ursolic acid, a selective inhibitor of 
cyclooxygenase-2 (Ringbom et al, 1998) and   oleanolic 
acid which acts through an opioid mechanism, and 
possibly, modulates vanilliod receptors (Maia et al, 
2006) have been reported to possess analgesic 
activities. 
5. Conclusion 
The result obtained in this study indicated that the root 
of P. maximum plant possesses a significant 
antiplasmodial and analgesic activities which justify the 
usage of this plant in the treatment of malaria and 
associated symptoms. 
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